Ronald Scheff
Impact in
Papers in
- Oncology 16
- Lung Cancer Research Studies 5
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Bryan J. Schneider (3 shared papers)Paul J. Christos (7 shared papers)Susan C. Pannullo (5 shared papers)John A. Boockvar (4 shared papers)Ashish Saxena (7 shared papers)Sherese Fralin (2 shared papers)Jared Knopman (2 shared papers)Howard A. Riina (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Critical Reviews in Oncology/Hematology (2 papers)Clinical Lung Cancer (2 papers)CA A Cancer Journal for Clinicians (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United StatesTürkiyeSpain
In The Last Decade
Ronald Scheff
24 papers receiving 912 citations
Ronald Scheff's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 446
- Genetics 150
- Pulmonary and Respiratory Medicine 247
- Immunology 108
- Radiology, Nuclear Medicine and Imaging 110
Countries citing papers authored by Ronald Scheff
This map shows the geographic impact of Ronald Scheff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Scheff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Scheff more than expected).
Fields of papers citing papers by Ronald Scheff
This network shows the impact of papers produced by Ronald Scheff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Scheff. The network helps show where Ronald Scheff may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald Scheff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial Hit paper breakdown → | 2021 | 221 |
| 2 | 2017 | 149 | |
| 3 | 2010 | 132 | |
| 4 | 2013 | 72 | |
| 5 | 2011 | 58 | |
| 6 | 2015 | 58 | |
| 7 | 2001 | 48 | |
| 8 | Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. | 2009 | 42 |
| 9 | 2015 | 29 | |
| 10 | Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. | 2012 | 20 |
| 11 | 2020 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2019 | 14 | |
| 14 | 2016 | 10 | |
| 15 | 2001 | 10 | |
| 16 | 2019 | 9 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 6 | |
| 19 | 2021 | 2 | |
| 20 | 2023 | 2 |
About Ronald Scheff
Ronald Scheff is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Neurology, having authored 26 papers that have together received 928 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Treatment and Pharmacology (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (446 citations), Genetics (150 citations), Pulmonary and Respiratory Medicine (247 citations), Immunology (108 citations) and Radiology, Nuclear Medicine and Imaging (110 citations). Ronald Scheff has collaborated with scholars based in United States, Türkiye and Spain. Frequent co-authors include Bryan J. Schneider, Paul J. Christos, Susan C. Pannullo, John A. Boockvar, Ashish Saxena, Sherese Fralin, Jared Knopman, Howard A. Riina, Jeffrey L. Port and Nasser K. Altorki. Their work appears in journals such as Journal of Clinical Oncology, Critical Reviews in Oncology/Hematology, Clinical Lung Cancer, CA A Cancer Journal for Clinicians and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.